NYLIM
BHVN

New York Life Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

New York Life Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-142,048
Closed -$21.5M – 1235
2022
Q3 		$21.5M Buy
142,048
+12,173
+9% +$1.84M 0.26% 75
2022
Q2 		$18.9M Buy
+129,875
New +$18.9M 0.22% 94